Dong-A develops third drug
Motilitone is Dong-A’s third homegrown medicine following Stillen and Zydena.
The company said that Motilitone was developed by a 6-year intensi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
